Collectively, these findings support the negative role of C-CBL in cancer cell migration and suggest its potential tumor suppressive function in cancers characterized by dysregulation in insulin receptor substrates 1 and 2 (Fig. 5). This evidence concerns the gene CBL and neoplasm.